Loading data for JBIO — first visit, this takes a few seconds.
Jade Biosciences, Inc.
19.90 +0.05 (0.25%)
17.89 +0.00%
- Capitalisation boursière
- $1.14B
- Volume
- 605K
- Prochaine publication des résultats
- Nov 12, 2026
Jade Biosciences, Inc. (JBIO) : cours, analyse et données
Valeur intrinsèque
Prévisions des analystes
Prévisions boursières →Derniers résultats
| Signalé | Écart estimé | Changement d’une année sur l’autre | |
|---|---|---|---|
| Chiffre d’affaires | — | n/a | n/a |
| EPS | -$0.76 | -$0.22 | +93.72% |
Métriques
- Cours acheteur
- 14.64
- Capitalisation boursière
- 1.14B
- Résultat net (ttm)
- -124M
- n/a
- -1.07
- n/a
- -6.72
- P/B (ttm)
- 2.58
- P/S (ttm)
- n/a
- Date des résultats
- Nov 12, 2026
- Cours vendeur
- 25.54
- Volume
- 605,018
- Volume moy. (20D)
- 1,015,188
- Ouverture
- 19.95
- Clôture précédente
- 19.85
- Fourchette du jour
- 19.70 - 20.35
- Intervalle de 52 semaines
- 6.91 - 28.00
- Analyste
- n/a
- Objectif de prix
- n/a
- Dividendes
- n/a
- Date ex-dividende
- n/a
À propos de Jade Biosciences, Inc.
Voir le profil →Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Industrie Biotechnology
Secteur Healthcare
Date d’introduction Jun 30, 2021
Employés 55
Bourse NasdaqCM
Symbole boursier JBIO
Site web https://jadebiosciences.com